Gufic Biosciences Limited

NSE GUFICBIO.NS

Gufic Biosciences Limited Inventory for the year ending March 31, 2024: USD 24.04 M

Gufic Biosciences Limited Inventory is USD 24.04 M for the year ending March 31, 2024, a 7.68% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Gufic Biosciences Limited Inventory for the year ending March 31, 2023 was USD 22.32 M, a 46.66% change year over year.
Gufic Biosciences Limited Inventory for the year ending March 31, 2022 was USD 15.22 M, a 18.05% change year over year.
Gufic Biosciences Limited Inventory for the year ending March 31, 2021 was USD 12.89 M, a -11.03% change year over year.
Gufic Biosciences Limited Inventory for the year ending March 31, 2020 was USD 14.49 M, a 6.80% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

NSE: GUFICBIO.NS

Gufic Biosciences Limited

CEO	Mr. Pranav Jayesh Choksi
IPO Date	Oct. 19, 2004
Location	India
Headquarters	SM House
Employees	1,491
Sector	Health Care
Industries Pharmaceuticals

Description

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

Key trends

Past 5 years